Storia in 4 fonti

Why Is Biohaven Stock Tumbling Today? - Biohaven (NYSE:BHVN)

Biohaven reports an FDA partial clinical hold on BHV-7000 new enrollment while keeping pivotal epilepsy trial data readouts on track.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

benzinga.comStai leggendo1 g fa

Why Is Biohaven Stock Tumbling Today? - Biohaven (NYSE:BHVN)

Biohaven reports an FDA partial clinical hold on BHV-7000 new enrollment while keeping pivotal epilepsy trial data readouts on track.

originale

endpoints.news1 g fa

FDA places partial hold on Biohaven's ion channel drug

An epilepsy study of the experimental drug called BHV-7000 was paused after regulators requested more information about preclinical safety data, Biohaven revealed in an SEC filing.

Leggi questa versione → originale

Timeline cronologica

giovedì 10 settembre 2026·biopharmadive.com
FDA places partial hold on Biohaven’s epilepsy drug
Announced mere weeks after Biohaven sold off rights to the therapy, opakalim, the halt affects a study some analysts believe is necessary to support a potential approval.
giovedì 10 settembre 2026·investors.com
Biohaven's Ratty Setback; How Xenon Benefits
Biohaven stock plummeted Thursday after the company paused enrollment in a midstage study of its seizure treatment.

Why Is Biohaven Stock Tumbling Today? - Biohaven (NYSE:BHVN)

FDA places partial hold on Biohaven's ion channel drug

Timeline cronologica

FDA places partial hold on Biohaven’s epilepsy drug

Biohaven's Ratty Setback; How Xenon Benefits

Biohaven's Ratty Setback; How Xenon Benefits

FDA places partial hold on Biohaven’s epilepsy drug

FDA places partial hold on Biohaven's ion channel drug

Why Is Biohaven Stock Tumbling Today? - Biohaven (NYSE:BHVN)